Pharmaceuticals

Industries

With the January 2018 implementation of USP <232>/<233> testing criteria for the measurement of elemental impurities in finished drug products, manufacturers must change from traditional wet chemistry methods to recommended instrumental techniques such as inductively couple plasma atomic emission spectrometry (ICP-AES) or inductively coupled plasma mass spectrometry (ICP-MS).

Teledyne CETAC offers a variety of sampling handing and sample introduction accessories for ICP-AES and ICP-MS enabling improved analysis of drug products.

Application Notes

Click on columns to sort

Title	Product	Release Date
Poster: Measurement of Elemental Impurities in a Higher Daily Dose Drug Product by USP <232>/<233> Using Ultrasonic Nebulization with ICP-AES Detection	U5000AT	03/16/2020
Rapid‐Throughput USP‐232/233 by Inductively Coupled Plasma Mass Spectroscopy	ASXPRESS PLUS	04/20/2016
Poster: Use of Ultrasonic Nebulization with ICP-AES for Enhanced Detection of Regulated Elements in Pharmaceuticals per USP <232>/<233>	U5000AT	04/20/2016
Measurement of Trace Elemental Impurities in Aspirin Using Ultrasonic Nebulization with ICP-OES Detection Following USP <232>/<233> Guidelines	U5000AT	08/29/2019
Automating Sample Preparation to meet USP <232>/<233> Guidelines	SimPrep	11/23/2020

About Teledyne CETAC

Teledyne CETAC products and services are used in every industry where rapid and accurate determination of elemental trace levels are required. Major industrial segments benefiting from our product-based solutions include semiconductor manufacturing, environmental analysis, and petrochemical manufacturing.